JNJ vs MKSI · P/E 17, rev $49.37B vs P/E 93, rev $2.33B
Johnson & Johnson (JNJ) versus MKS Instruments Inc (MKSI) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
MKS Instruments Inc (MKSI) is a scientific & technical instruments company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported MKSI revenue for 2026-06-30 was $2.33B. Net income was $258.0M. MKSI currently screens at market cap $30.04B and trailing P/E 93.4.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. MKSI currently screens at market cap $30.04B and trailing P/E 93.4.
Not investment advice. Open the JNJ and MKSI stock pages for the full models.
Not investment advice.